We compared the clinical features, laboratory and coronary angiographic findings, treatments,
and outcomes among patients with ST-segment elevation myocardial infarction (MI) with …

Background— Ticagrelor, when compared with clopidogrel, reduced the 12-month risk of
vascular death/myocardial infarction and stroke in patients with ST-elevation acute coronary …

Background: Baseline Q waves may provide additional value compared with time from the
onset of symptoms in predicting outcomes for patients with ST-segment elevation. We …

BACKGROUND: Atrial infarction reportedly occurs in 0.7% to 52% of ST-elevation myocardial
infarctions (STEMIs), up to two thirds of whom develop atrial fibrillation and flutter (AF). …

BACKGROUND: Aborted myocardial infarction (AbMI) in patients with ST-elevation MI
defined by ST resolution with less than 2-fold elevation in biomarkers has been previously …

BACKGROUND: Primary percutaneous coronary intervention (PCI) has emerged as the
preferred therapy for acute ST-elevation myocardial infarction (STEMI) provided it is performed …

… The results of thymidine uptake experiments show that exogenously expressed Notch1
severely reduced incorporation of thymidine by HPV-containing cells (HeLa, SiHa), indicating …

Methotrexate (MTX) is an efficient chemotherapeutic and immunosuppressant drug, but the
hepatotoxicity of MTX limits its clinical use. Naringin (Nar) is a flavonoid derived from Citrus …

Background and purpose Rheumatoid arthritis (RA) is a chronic, systemic autoimmune
inflammatory disease which poses a need to explore effective yet safe pharmacotherapeutic …

… in B-myb/DREAM expression in CaSki and SiHa cells, at least when compared to the T98G
cell control… Firstly, we depleted the Lin-54 gene in T98G, SiHa and CaSki cells followed by co-…